✦ LIBER ✦

A changing world for DCvax: a PSMA loaded autologous dendritic cell vaccine for prostate cancer

✍ Scribed by Fishman, Mayer

Book ID: 118134095
Publisher: Informa plc
Year: 2009
Tongue: English
Weight: 733 KB
Volume: 9
Category: Article
ISSN: 5847-4714
DOI: 10.1517/14712590903446921

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

DCVax®- DIRECT: autologous activated den

DCVax®- DIRECT: autologous activated dendritic cells for image guided intra-tumoral vaccination in patients with solid tumors - a phase I/II clinical trial in progress

✍ Vivek Subbiah,Ravi Murthy,Chitra Hosing… 📂 Article 📅 2013 🏛 Springer (Biomed Central Ltd.) 🌐 English ⚖ 69 KB

Improved Survival Benefit of Autologous

Improved Survival Benefit of Autologous Dendritic Cell–Based Vaccine for Hormone Refractory Prostate Cancer: A Retrospective Subset Analysis of the D9901 Trial

✍ Price, Nancy; Sartor, Oliver 📂 Article 📅 2004 🏛 CIG Media Group, LP. 🌐 English ⚖ 52 KB

A Phase I vaccine trial using dendritic

A Phase I vaccine trial using dendritic cells pulsed with autologous oxidized lysate for recurrent ovarian cancer

✍ Lana E Kandalaft, Cheryl L Chiang, Janos Tanyi… 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 476 KB

Autologous Dendritic Cells Pulsed with P

Autologous Dendritic Cells Pulsed with Prostatic Acid Phosphatase (APC8015) for Patients with Hormone- Refractory Prostate Cancer with a Gleason Score ≤ 7

✍ Lee, David; Sartor, Oliver; Jain, Vinay K. 📂 Article 📅 2003 🏛 CIG Media Group, LP. 🌐 English ⚖ 203 KB

A phase I/II trial of IDD-6, an autologo

A phase I/II trial of IDD-6, an autologous dendritic cell vaccine for women with advanced ovarian cancer in remission

✍ C. Chu; J. Boyer; P. Gimotty; S. Rubin; G. Coukos; M. Morgan; J. Bender; C. June 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 54 KB

Phase I clinical trial: T-cell therapy f

Phase I clinical trial: T-cell therapy for prostate cancer using autologous dendritic cells pulsed with HLA-A0201-specific peptides from prostate-specific membrane antigen

✍ Murphy, G.; Tjoa, B.; Ragde, H.; Kenny, G.; Boynton, A. 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 791 KB

## BACKGROUND. Conventional treatment for metastatic prostate cancer have failed to demonstrate curative potential in all patients. Investigations involving the role of T-cell immunity in the clearance of neoplastic cells are now available. Development of T-cell immunotherapy may give a new approa